Artemis Medicare Services Limited has informed the Exchange regarding Change in Director(s) of the company.
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare reported strong FY25 results with revenue from operations rising about 8% to Rs. 913.26 crore (from Rs. 845.23 crore) and net profit after tax surging roughly 70% to Rs. 83.46 crore (from Rs. 49.15 crore). Q4 FY25 was also robust, with net profit up about 67% YoY to Rs. 23.20 crore on revenue of Rs. 234.80 crore. The board recommended a final dividend of Rs. 0.45 per share (45%) for FY25, subject to shareholder approval. On the board front, Mr. Sunam Sarkar was appointed as an Additional Non-Executive Non-Independent Director, Dr. Nirmal Kumar Ganguly resigned as Non-Executive Non-Independent Director citing personal reasons, and Ms. Deepa Gopalan Wadhwa will step down on May 21, 2025 on completion of her Independent Director term. M/s. DMK Associates was appointed as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30).
Sharply higher profits and a 45% dividend are positive for shareholders and likely supportive of the stock, while the director changes appear routine — one personal-reason resignation and one normal term-end, balanced by a new appointee.